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Most non-Hodgkin’s lymphoma (NHL) originates in the lymph
nodes or other lymphoid tissues. However, a significant proportion
of NHL has a primary extranodal site such as the gastrointestinal
tract, skin or central nervous system. Primary gastrointestinal
NHL is the commonest extranodal localization, representing
around one-third of all extranodal cases in most series (Zucca et al,
1997). Recently it has been shown that incidence rates for NHL
have been increasing for many years with this trend being more
prevalent in extranodal disease than in nodal NHL (Devesa and
Fears, 1992; Zheng et al, 1992). It is, as yet, uncertain as to
whether this is a real increase or due to more efficient case regis-
tration and improved diagnoses although it has been suggested that
the increase in incidence rates for gastric lymphoma in the United
States is independent of coding and diagnostic procedures
(Severson and Davis, 1990).
In 1984 the Leukaemia Research Fund began the Data
Collection Survey (DCS), a specialist population-based register
covering neoplastic haematological diseases in parts of England
and Wales based on diagnoses from collaborating haematologists
and histopathologists. Data collected by this Survey have been
shown to be more accurate, as they reflect modern clinical and
haematopathological opinions, and more complete than compara-
tive National Health Service cancer registry data (Alexander et al,
1989; Cartwright et al, 1997).
This paper describes the epidemiology of gastrointestinal NHL
and investigates the changes in incidence in gastric and other
intestinal NHL in those areas of England and Wales covered by the
DCS from 1986 to 1993.
MATERIALS AND METHODS
The DCS is a specialist registry of lymphomas, leukaemias and
related disorders held by the Leukaemia Research Centre for
Clinical Epidemiology in Leeds. This survey has been collecting
data since 1 January 1984, with the aim of providing high quality
data for population-based epidemiological studies (Cartwright et
al, 1990). The geographical area of case collection covers approx-
imately half of England and Wales. Newly diagnosed cases are
reported directly to Leeds from collaborating histopathologists and
haematologists and registrations completed by trained data collec-
tion clerks. In addition, regular checks are made with NHS cancer
registries for the areas concerned and any missed cases registered
after review.
NHL cases were registered by the DCS only after histopatho-
logical review by a minimum of two histopathologists with a
specialist interest in lymphomas. Data from the DCS and the
cancer registries for the years 1989–93 were compared using log-
linear models and case coverage for all NHL was estimated to be
nearly 96% (Cartwright et al, 1997).
Gastrointestinal NHL was defined as cases where the initial
symptoms and predominant disease were confined to the gastro-
intestinal tract (Lewin et al, 1978) including the pancreas and
oesophagus. Cases with a gastrointestinal site discovered during
staging or other clinical investigation of NHL and mesenteric
localizations were excluded from the study. In accordance with
DCS criteria, cases were registered as primary gastrointestinal
NHL, after histopathological review with no evidence of nodal
involvement.
The localization of gastrointestinal NHL was further classified
into gastric, small bowel and large bowel NHL, and gastrointestinal
(GI) tract, site unknown, NHL by review of the histopathology
reports. The gastric site comprised those cases where the disease
was localized in the stomach or in the stomach and intestine. Small
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bowel included duodenum, jejunum, ileum, ileo caecal junction
localizations and small intestine not otherwise specified. The large
bowel included appendix, caecum, colon, rectum localizations and
large intestine not otherwise specified. A separate category of GI
tract, site unknown, NHL included cases where the primary site had
not been recorded and cases where the site was reported as
intestinal or gastrointestinal with no further details.
Gastrointestinal NHL was classified according to the updated
Kiel classification and graded as either low- or high-grade malig-
nancy (Stansfeld et al, 1988).
This study was based on all gastrointestinal NHL cases
diagnosed between 1 January 1986 and 31 December 1993 and
reported to the DCS. Age-specific incidence rates were calculated
for males, females and both sexes combined for all gastrointestinal
NHL, and individually for gastric, small bowel, large bowel sites
and GI tract, site unknown. To calculate age-specific incidence
rates, cases were grouped into 5-year age groups with the excep-
tion of the final group which was 90 years and older. To facilitate
geographical comparisons, rates were standardized by the direct
method using the World Standard Population (Parkin et al, 1992)
which required adjustment of the final age group to 85 years and
older. Incidence trends were evaluated by Poisson regression
analysis over the full age range for all gastrointestinal NHL and
for the individual sites. Incidence trends were also investigated,
where sufficient data were available, using four age ranges (0–29,
30–49, 50–69 and 70+ years) to examine in more detail whether
changes in incidence rates were more prominent in some age
groups than in others.
RESULTS
Incidence of gastrointestinal NHL
A total of 1069 cases of gastrointestinal NHL were diagnosed
during the years from January 1986 to December 1993. During
this time, 11334 cases of NHL were diagnosed within the popula-
tion covered by the Data Collection Survey, thus the gastro-
intestinal NHL cases represented 9.43% of all NHL cases.
Table 1Age-standardized incidence rates and site distribution for gastrointestinal non-Hodgkin’s lymphoma, 1986–1993
Male Female Total
Ratea Number % Ratea Number % Ratea Number % M:F
Site of cases of cases of cases ratio
Gastric 0.29 252 41.1 0.20 211 46.2 0.24 463 43.3 1.5
Small bowel 0.22 167 27.3 0.13 126 27.6 0.17 293 27.4 1.7
lleum 29 23 52
Duodenum 11 7 18
NOS 127 96 223
Large bowel 0.09 71 11.6 0.04 48 10.5 0.06 119 11.1 2.3
Rectum 25 18 43
Colon 21 15 36
Caecum 20 9 29
NOS 5 6 11
Gl tract, site unknown 0.13 107 19.9 0.06 65 15.7 0.10 172 16.1 2.2
Gastrointestinal NOS 84 60 144
Intestine NOS 23 5 28
All sitesb 0.75 612 100.0 0.43 457 100.0 0.58 1069 100.0 1.7
aRate directly standardized to the World Standard population (cases/100000/year). bIncludes gastrointestinal NHL with the primary site localized to the
pancreas (n = 14) and oesophagus (n = 8).
Table 2Classification of gastrointestinal NHL by grade and age
Age range Sex Low-grade High-grade T-cell All graded Unclassified Total
(years) cases cases
0–14 M 0 11 (100.0%)a 0 11 1 (8.3%)b 12
F 0 1 (100.0%) 0 1 0 1
15–29 M 2 (10%) 16 (80.0%) 2 (10%) 20 1 (4.8%) 21
F 0 1 (50.0%) 0 1 1 (50.0%) 2
30–49 M 26 (36.6%) 40 (56.3%) 5 (7.1%) 71 9 (11.3%) 80
F 14 (35.0%) 24 (60.0%) 2 (5.0%) 40 10 (20.0%) 50
50–69 M 81 (37.0%) 117 (53.4%) 21 (9.6%) 219 47 (17.7%) 266
F 72 (45.3%) 76 (47.8%) 11 (6.9%) 159 34 (17.6%) 193
70+ M 76 (40.9%) 102 (54.8%) 8 (4.3%) 186 47 (20.2%) 233
F 53 (33.5%) 89 (56.3%) 16 (10.1%) 158 53 (25.1%) 211
a% of all graded cases. b% of total cases.Epidemiology of gastrointestinal NHL 1931
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Age-standardized (World standard population) incidence rates
for all gastrointestinal NHL and by individual site are presented in
Table 1. The overall age-standardized incidence rates for gastro-
intestinal NHL all sites combined were 0.75 per 100 000 and 0.43
per 100 000 for males and females respectively. Ages ranged
between 5 years 1 month and 95 years 9 months (mean = 64 years
10 months, median = 67 years 6 months). An excess in male
incidence was found for all gastrointestinal NHL and for the indi-
vidual sites ranging from a male:female ratio of 1.5:1 for gastric
NHL to 2.3:1 for large bowel NHL. This excess in male cases was
even more pronounced in children and young adults where 11 of
12 cases in the 0–14 age range and 21 of 23 cases in the 15–29 age
range were male (Table 2).
Site of gastrointestinal NHL
Table 1 also shows that the most common site of gastrointestinal
NHL for all age groups was gastric (43.3%) followed by small
bowel (27.4%), large bowel (11.1%) with a further 172 cases
classified as GI tract, site unknown, NHL (16.1%). However, for
children and young adults (< 30 years) small bowel NHL was
predominant (44.4%), then GI tract, site unknown (25.0%), gastric
(16.7%) and large bowel (13.9%).
Histology of gastrointestinal NHL
Overall, most gastrointestinal NHL cases in this series were high-
grade (44.5%), with 30.4% low-grade, 19.0% unclassified and
6.1% T-cell lymphomas. The distribution of histological subtypes
among gastrointestinal sites is given in Table 3. Gastric NHL had a
higher proportion of low-grade cases whereas intestinal NHL
Table 3 Histological classification of gastrointestinal NHL for individual sites
Histology Gastric Small bowel Large bowel Gl tract,
site unknown
Low grade 153 75 35 54
(43.3%) (30.4%) (33.0%) (33.8%)
Lymphoplasmacytoid 10 4 3 4
Centrocytic 18 12 13 8
Centroblastic-centrocytic, follicular 28 19 5 8
Centroblastic-centrocytic, follicular and diffuse 6 9 1 6
Centroblastic-centrocytic, diffuse 31 14 5 16
Low grade, unclassified 60 17 8 12
High grade 191 131 62 81
(54.1%) (53.0%) (58.5%) (50.6%)
Centroblastic 75 38 21 26
Lymphoblastic, Burkitt’s type 0 3 3 3
Lymphoblastic, convoluted cell 1 0 0 0
Lymphoblastic, other/unclassified 6 5 2 7
Immunoblastic 11 12 11 10
Histiocytic lymphoma 10 11 6 4
High grade, unclassified 88 62 19 31
T-cell lymphoma NOS 9 41 9 6
(2.5%) (16.6%) (8.5%) (3.8%)
All classified cases 353 247 106 141
(100%) (100%) (100%) (100%)
Malignant lymphoma, unspecified grade (% of total cases) 110 46 13 31
(23.8%) (15.7%) (10.9%) (18.0%)
Total cases 463 293 119 172
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Figure 1 Age-specific incidence rates, male (– – –), female (- - -) and
combined (— —), for all gastrointestinal NHL (A), gastric NHL (B), small bowel
NHL (C), large bowel NHL (D) and Gl tract, site unknown, NHL (E) in parts of
England and Wales, 1986–19931932 KA Gurney et al
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(small and large bowel cases combined) tended to be high-grade.
Over 75% of T-cell lymphomas were found in intestinal NHL
cases. For all gastrointestinal NHL the most common histological
subtype was centroblastic, accounting for nearly 20% of all classi-
fied lymphomas. All childhood, and the majority of young adult,
gastrointestinal NHL cases were high-grade malignancies. In chil-
dren (0–14 years) most cases were lymphoblastic, Burkitt’s type,
but in the young adults (15–29 years) centroblastic was again
predominant. In adults (³30 years old) the distribution of high-
grade, low-grade and T-cell gastrointestinal NHL were broadly
similar for each age range.
Age-specific incidence curves by sex for all gastrointestinal
NHL and by individual site are shown in Figure 1. Incidence rates
for both sexes show broadly similar patterns for all sites of
gastrointestinal NHL. Rates are very low for the under 30s then
rapidly increase to a major peak around 80 ±5 years of age, except
in large bowel NHL where this peak occurs over a narrower age
range and GI tract, site unknown, NHL, where the age range is
rather broader. All sites appear to show a minor peak in age-
specific incidence rates for the 55–60 year age group with the
exception of GI tract, site unknown, NHL where the peak occurs
much earlier at 40–45 years of age.
Change in incidence
From 1986 to 1993, incidence of gastrointestinal NHL for both
sexes combined increased by 2.66% per annum (P= 0.047; 95%
CI, 0.03, 5.30) (Table 4). Over this time period the incidence of
NHL classified as having a primary site in the stomach or small
bowel showed significant annual increases of 6.25% and 5.87%,
respectively whilst that of large bowel NHL remained stable. A
highly significant annual decrease of 12.62% in the incidence of
GI tract, site unknown, NHL was also observed. Similar values for
annual increases and decreases were seen in males and females
separately but for the female population these trends were not
significant except for GI tract, site unknown, NHL. In males,
gastric and GI tract, site unknown, NHL incidence rates showed a
significant increase and decrease respectively.
More detailed analyses of the increase in incidence rates from
1986 to 1993 for all gastrointestinal NHL revealed that significant
increases were restricted to the older age groups (0–29 years,
+ 5.5%, NS; 30–49 years, – 2.6%, NS; 50–69 years, + 3.5%, P=
0.09; 70+ years, + 5.3%, P= 0.01; males and females combined).
This pattern was also seen for gastric NHL (70+ years, + 8.5%,
P= 0.02). Analyses for other sites and age ranges were unreliable
due to small numbers of cases.
Time trend analyses for low- and high-grade gastrointestinal
NHL at all sites showed no significant changes for either of these
groups (low-grade disease showed an annual decrease of 1.7%,
NS; high-grade disease showed an annual increase of 1.5%, NS;
males and females combined). However, cases with unspecified
grade showed an annual increase of 7.15%, P= 0.02 reflecting the
relatively high proportion of gastric and small bowel cases with
unknown grade.
DISCUSSION
The majority of studies investigating the epidemiology of gastro-
intestinal NHL have been based on studies using selective data with
the exception of four north European population-based studies
[Otter et al, 1989a(96 cases); D’Amore et al, 1994 (306 cases);
Halme et al, 1997 (61 cases); Ducreux et al, 1998 (78 cases)]. To
our knowledge, this study comprising 1069 cases represents the
largest population-based series of gastrointestinal NHL. This, along
with uniform and highly complete collection of data, are the main
strengths of the current study. The principal disadvantages are those
shared by similar studies in that it is not known whether all extra-
nodal disease has been included, the site may be vague in some
cases and it is not always possible to distinguish a nodal condition
infiltrating into the bowel from primary bowel disease.
Table 4Time trend analysis of incidence rates of gastrointestinal NHL in parts of England and Wales, 1986–1993
Annual change 95% confidence
in incidence intervals
All gastrointestinal NHL
Males + 2.19% NS
Females + 3.16% NS
Total + 2.66% P = 0.047 0.03, 5.30
Gastric
Males + 6.88% P = 0.014 1.34, 12.72
Females + 5.37% NS
Total + 6.25% P = 0.003 2.16, 10.51
Small bowel
Males + 5.65% NS
Females + 6.08% NS
Total + 5.87% P = 0.023 0.78, 11.23
Large bowel
Males – 0.03% NS
Females + 3.45% NS
Total + 1.44% NS
Gl tract, site unknown
Males – 13.29% P = 0.001 – 5.31, – 20.61
Females – 11.68% P = 0.026 – 1.21, – 21.04
Total – 12.62% P < 0.001 – 6.36, – 18.47Epidemiology of gastrointestinal NHL 1933
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The incidence rates found in this study for gastrointestinal NHL
in parts of England and Wales are lower than those reported by
previous population-based studies in France, central Finland and
Denmark (D’Amore et al, 1994; Halme et al, 1997; Ducreux et al,
1998). This difference is more marked for gastric NHL, where
incidence is less than half that found in other European countries,
than for intestinal NHL where the rates are more similar to those
reported. Incidence rates calculated from cancer registry data for
14 countries by Newton et al (1997) also showed that England and
Wales had the lowest rate of gastric NHL of all developed coun-
tries and that small intestine NHL rates showed much less varia-
tion. These authors calculated incidence rates of 0.21, 0.16 and
0.08 per 100 000 for gastric, small intestine and colon NHL,
respectively, which are very similar to the rates found in the
present study.
Other epidemiological characteristics of gastrointestinal NHL in
the present study were comparable to earlier studies, with nearly
half of gastrointestinal NHL cases localized to the stomach, and
small bowel and large bowel lymphomas representing just over
one quarter and one-tenth of cases, respectively (Halme et al,
1997; Zucca et al, 1997). Gastrointestinal NHL in children and
young adults (< 30 years old) was more commonly found in the
small bowel rather than the stomach. A hospital-based series
reviewed by Weingrad et al (1982) found that 73% of patients had
a primary gastric lymphoma but this series did not include children
who typically have relatively more intestinal disease than adults.
In other studies, a greater proportion of large bowel to small bowel
NHL probably reflects the inclusion of mesenteric presentations in
the former group, whilst in this study these have been recorded as
nodal disease and have not been included in the analyses for
gastrointestinal NHL (Otter et al, 1989b; Ducreux et al, 1998). In
addition, there is considerable evidence that geographical variation
exists. Among demographically similar communities in the UK
and Italy, large differences in the incidence of gastric lymphoma
have been reported (Doglioni et al, 1992). The higher incidence of
gastric lymphoma found in Italy was associated with excesses in
gastric adenocarcinoma and Helicobacter pylori infection which
may be involved in the development of both neoplasms. H. pylori
infection has been implicated in the development of low-grade
gastric lymphoma derived from mucosa-associated lymphoid
tissue (MALT) (Wotherspoon et al, 1991). In Middle Eastern and
Mediterranean populations there is a relatively high incidence of
small bowel NHL linked to immunoproliferative alpha-chain
disease. A similar hypothesis, involving a putative microorganism,
has been postulated to operate in immunoproliferative small intes-
tine lymphomas (Isaacson and Spencer, 1993). The importance of
H. pylori infection in the aetiology of gastric lymphoma is still
uncertain. There have been several reports of successful treatment
of low-grade gastric lymphoma with antibiotics alone but MALT
formation leading to B-cell clonality and lymphoma may not be
linked exclusively to H. pylori infection (Sorrentino et al, 1996).
Gastrointestinal NHL is principally a disease of middle age and
older with nearly 85% of cases in this series aged over 50 years.
Male predominance, found to be around 2:1 depending on the site,
has been observed in all series whether population- or hospital-
based, although there is as yet no explanation for this excess. The
distribution of low- and high-grade gastrointestinal NHLs in this
series is similar to that found in previous studies with more cases
of high-grade disease than low-grade disease overall. However,
there are differences between the individual sites with low-grade
NHL more common in gastric disease and high-grade NHL more
common in intestinal disease. T-cell lymphomas were found
mostly in intestinal NHL cases as expected.
There have been several reports recently that the incidence of
NHL malignancies is increasing rapidly, primarily in the devel-
oped countries, by between 3–5% per annum (Devesa and Fears,
1992; McNally et al, 1997; Morgan et al, 1997) and that this
increase is seen more in extranodal disease than in nodal NHL
(Devesa and Fears, 1992; Zheng et al, 1992).
In the period from 1986 to 1993 the incidence of gastrointestinal
NHL of all sites in England and Wales increased by more than
2.5% annually. This is the first report of an increase in gastro-
intestinal NHL in Europe. More detailed analyses showed that this
increase was limited to the older age groups with a moderate
increase in the 50 to 69-year-old age group and the largest increase
in the over 70-year-old group as has been found in the United
States for gastric lymphomas (Severson and Davis, 1990).
Incidence rates of gastric and small bowel NHL each showed
annual increases of around 6%. In the United States an annual
increase of 3.7% in small intestinal NHL was found during the
period 1974 to 1988 and rises in incidence rates for gastric
lymphoma have been reported (Severson and Davis, 1990; Devesa
and Fears, 1992).
Epidemiological studies have identified a number of factors
which may be of importance in the aetiology of NHL, though not
specifically to gastrointestinal NHL. These include exposure to
ultraviolet light, to pesticides, solvents and other chemicals and the
excess of protein and fat in the diet (Franceschi et al, 1989;
Cartwright et al, 1994). Increasing exposure or susceptibility to
these environmental risk factors could be responsible for the
increasing trend in gastrointestinal NHL. Greater awareness of H.
pylori may result in more cases of gastrointestinal NHL, and in
particular MALT lymphomas, being identified. This series
included no data on MALT lymphomas, however, as these
lymphomas are typically low-grade malignancies and no increase
in low-grade disease was seen over the period from 1986–1993 it
seems unlikely that this could account for the observed increase in
gastric NHL incidence. Alternatively, endoscopic biopsies and
diagnostic techniques may have led to increased accuracy in the
diagnosis of gastrointestinal NHL. Worldwide, incidence rates of
gastric cancer have declined over recent years (Coleman et al,
1993). This has been cited as evidence against an improvement in
diagnoses but neoplasms previously diagnosed as gastric carci-
nomas may now be more accurately diagnosed as lymphomas.
The most obvious conclusion in this series would be that
improved diagnosis of gastrointestinal NHL in the 1990s may be
responsible, at least in part, for the observed increases in gastric
and small bowel NHL, as a concomitant decrease in the incidence
of gastrointestinal NHL of unknown primary site was observed.
However, a real increase in gastric and small bowel lymphoma
cannot be excluded given that an annual increase of more than
2.5% in the incidence of gastrointestinal NHL at all sites was
observed in England and Wales between 1986 and 1993.
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